Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2019-01-25 | Philip H. Hosbach, IV, age 56, recently retired from Sanofi Pasteur as Vice President, Global Public Affairs for Vaccines. His prior roles with Sanofi Pasteur included Vice President, New Products and Immunization Policy and Vice President, Global Vaccine Public Affairs. He was also a member of Sanofi Pasteur’s board of directors and executive committee. Mr. Hosbach was previously a director of the Company from 2014 to 2016 at which time he resigned following his acceptance of a career assignment overseas. Mr. Hosbach is a respected senior leader with over 31 years of experience, holding executive positions in clinical research, research and development, advocacy, government relations, and commercial operations, including marketing and sales. His interdisciplinary expertise ranges in public affairs, global corporate governance, public policy, and U.S. federal and state government relations. Mr. Hosbach’s significant government relations, marketing and sales experience are of great benefit to the Board of Directors. |
| 2020-01-24 | Philip H. Hosbach, IV, age 57, is a retired executive from Sanofi Pasteur where he was Vice President, Global Public Affairs for Vaccines. He is currently an independent consultant working with pharmaceutical and healthcare companies. |
| 2021-01-25 | Philip H. Hosbach, IV, age 58, is a retired executive from Sanofi Pasteur where he was Vice President, Global Public Affairs for Vaccines. He is currently an independent consultant working with pharmaceutical and healthcare companies. |
| 2022-01-24 | Philip H. Hosbach, IV, age 59, is a retired executive from Sanofi Pasteur where he was Vice President, Global Public Affairs for Vaccines. He is currently an independent consultant working with pharmaceutical and healthcare companies. His prior roles with Sanofi Pasteur included Vice President, New Products and Immunization Policy and Vice President, US Vaccine Public Affairs. He was also a member of Sanofi Pasteur’s board of directors and executive committee. |
| 2023-01-25 | Philip H. Hosbach, IV, age 60, is a retired executive from Sanofi Pasteur where he was Vice President, Global Public Affairs for Vaccines. His prior roles included Vice President, New Products and Immunization Policy and Vice President, US Vaccine Public Affairs. |
| 2024-01-25 | Philip H. Hosbach, IV, age 61, is a retired executive from Sanofi Pasteur where he was Vice President, Global Public Affairs for Vaccines. He is currently an independent consultant working with pharmaceutical and healthcare companies. |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-04-09